Multiple sclerosis disease rebound after treatment switch from fingolimod to alemtuzumab

M Willis, O Pearson, Zsolt Illés, C Nielsen, Tobias Sejbæk Mathiesen, Martin Duddy, K Petheram, C van Munster, J Killestein, B Uitdehaag, C Malmestrom, E Tallantyre, N Robertson

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskning

OriginalsprogEngelsk
Publikationsdato14. sep. 2016
StatusUdgivet - 14. sep. 2016
Begivenhed32nd ECTRIMS: Congress of the European Committee for Treatment and Research in Multiple Sclerosis - ExCeL London, London, Storbritannien
Varighed: 14. sep. 201617. sep. 2016

Konference

Konference32nd ECTRIMS
LokationExCeL London
Land/OmrådeStorbritannien
ByLondon
Periode14/09/201617/09/2016

Citationsformater